Study Stopped
Study was terminated due to the untimely death of the investigator
ACP for Local Application in Ankle Arthrodesis
Autologous Concentrated Platelet-rich Plasma (Arthrex ACP®) for Local Application in Ankle Arthrodesis: A Prospective Outcome Analysis.
1 other identifier
interventional
10
1 country
1
Brief Summary
To compare the outcomes of patients who undergo three different types of surgeries for ankle fusion and reconstruction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 26, 2010
CompletedFirst Posted
Study publicly available on registry
May 27, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedResults Posted
Study results publicly available
November 13, 2014
CompletedNovember 13, 2014
November 1, 2014
9 months
May 26, 2010
July 29, 2014
November 12, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
CT Scan for Fusion Analysis
There will be no outcome analysis for the CT scan performed on the 10 patients due to the death of the primary investigator.
8 weeks post op.
Study Arms (3)
Fusion+ACP+Autograft
ACTIVE COMPARATORStandard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus, external rotation and neutral foot dorsiflexion). The arthrodesis undertaken for all groups will be the standard arthroscopic ankle arthrodesis with portals to the ankle (anterior medial / anterior lateral), skin incision only technique with dissection through the capsule and penetration to the joint. Standard debridement of the gutters, tibia osteophyte, tibia-talor joint resection and autograft preparation will be performed in the joint. Depending on randomization of the subject, (Autologous concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and reduced.
Fusion + ACP +DBM
ACTIVE COMPARATORStandard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus and external rotation and neutral foot dorsiflexion). Depending on the randomization of the subject, (Autologous Concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and then reduced.
Standard-Fusion +Autograft only
NO INTERVENTIONStandard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus and external rotation and neutral foot dorsiflexion). The arthrodesis undertaken for all groups will be the standard arthroscopic ankle arthrodesis with portals to the ankle (anterior medial / anterior lateral), skin incision only technique with blunt dissection through the capsule and penetration to the joint. Depending on the randomization of the subject, ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and then reduced.
Interventions
Autologous blood products have created a growing interest for use in a number of orthopedic therapies. The healing effects of plasma are supported by growth factors released by platelets. These growth factors induce a healing process wherever they are applied. The Arthrex ACP System is a cost-effective method of concentrating growth factors for therapeutic use.
Eligibility Criteria
You may qualify if:
- patients whom present the need for the elective surgery
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia Orthopedic Group
Columbia, Missouri, 65201, United States
Results Point of Contact
- Title
- Vicki L Jones, Research Coordinator
- Organization
- ColumbiaOG
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Shurnas
Columbia Orthopaedic Group
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sr. Research Coordinator
Study Record Dates
First Submitted
May 26, 2010
First Posted
May 27, 2010
Study Start
October 1, 2009
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
November 13, 2014
Results First Posted
November 13, 2014
Record last verified: 2014-11